Ensysce Biosciences
ENSC
ENSC
8 hedge funds and large institutions have $1.15M invested in Ensysce Biosciences in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
8
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$705K | |
| 2 | +$407K | |
| 3 | +$24K | |
| 4 |
Morgan Stanley
New York
|
+$423 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$65 |
Top Sellers
| 1 | -$279K | |
| 2 | -$236K | |
| 3 | -$56.3K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$11.1K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$5.67K |